Aim Immunotech (AIM) Debt by Year
Aim Immunotech carried $927K in long-term debt against $3.0M in cash and equivalents at the end of fiscal year 2025. This represents a decrease of 67.0% from the prior fiscal year. The table below carries 15 fiscal years, from 2011 to 2025, and the quarters Aim Immunotech has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
AIM Debt & Cash by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | FY2510-K | FY2410-K | FY2310-K | FY2210-K | FY2110-K | FY2010-K | FY1910-K | FY1810-K | FY1710-K | FY1610-K | FY1510-K | FY1410-K | FY1310-K | FY1210-K | FY1110-K |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | $927K-67.0% | $2.8M | N/A | N/A | N/A | $1.9M-10.8% | $2.1M-9.2% | $2.3M | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash & Equivalents | $3.0M+75.5% | $1.7M-68.7% | $5.4M-79.9% | $27.1M-15.7% | $32.1M-16.6% | $38.5M+2519.1% | $1.5M+391.6% | $299K-78.8% | $1.4M-41.4% | $2.4M+13.9% | $2.1M-1.9% | $2.2M+168.5% | $803K-63.7% | $2.2M-28.7% | $3.1M |
AIM Debt & Cash by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q | Q1'2410-Q | Q4'2310-K | Q3'2310-Q |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | $3.6M+33.1% | $210K-91.2% | $927K-67.0% | N/A | $2.7M+861.5% | $2.4M+151.2% | $2.8M | $139K | $283K | $950K | N/A | N/A |
| Cash & Equivalents | $9.9M+1979.8% | $5.8M+547.7% | $3.0M+75.5% | $2.3M+156.5% | $476K-86.6% | $898K-72.7% | $1.7M-68.7% | $915K-94.0% | $3.6M-83.1% | $3.3M-85.9% | $5.4M-79.9% | $15.3M-48.7% |
What long-term debt means
Long-term debt is borrowing that falls due more than a year out, and the cash line beside it is what the company held on the same balance sheet date.
More Aim Immunotech financials
Frequently Asked Questions
What was Aim Immunotech's long-term debt in fiscal year 2025?
Aim Immunotech carried $927K in long-term debt against $3.0M in cash and equivalents at the end of fiscal year 2025.
How fast is Aim Immunotech's long-term debt growing?
Aim Immunotech (AIM) long-term debt fell by 67.0% year over year, from $2.8M to $927K in fiscal year 2025.
What was Aim Immunotech's long-term debt in the most recent quarter?
Aim Immunotech (AIM) reported $3.6M in long-term debt in Q2 2026. This represents an increase of 33.1% from the same quarter a year earlier.
What does long-term debt mean on a financial statement?
Long-term debt is borrowing that falls due more than a year out, and the cash line beside it is what the company held on the same balance sheet date. This page lists what Aim Immunotech (AIM) reported on that line in every period on record.